estrogen replacement therapy reduces the risk of colorectal cancer

There's increasing evidence that estrogen replacement therapy reduces the risk of colorectal cancer.

This benefit started showing up several years ago.

Now it seems that estrogen lowers the risk of colorectal cancer by about a third.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote